Welcome to our exciting section on the EULAR–EMEUNET Journal Club within the EULAR  School of Rheumatology!


The 6th edition of our Twitter Journal Club is taking place on:

6th of February 2019 at 8:30pm GMT / 9:30pm CET!

The EULAR School of Rheumatology Faculty selected the paper by McGarry et al, published in Arthritis & Rheumatology, to be discussed in the Journal Club

JAK/STAT Blockade Alters Synovial Bioenergetics, Mitochondrial Function, and Proinflammatory Mediators in Rheumatoid Arthritis

The full text of the paper is free to view

Find here the accompanying Press Review Journal Club Newsletter incorporating a recent review on current Rheumatology literature as well as information about the paper selected for the JC and the EMEUNET paper of the month.

We sincerely congratulate Andreas Kronbichler for winning the EMEUNET paper of the month: Trimethoprim–sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis published in Annals of the Rheumatic Diseases.

Andreas was interviewed by Diederik De Cock and Polona Zigon about his work. Find it on our EMEUNET TUBE

Don’t forget to follow us @EULAR_JC @eular_org and @EMEUNET for details

of our upcoming JC!

To make your discussion during our Journal Club easier and more focused we recommend using tchat to follow the course of the JC. Tchat allows you to select to follow only one hashtag. To follow the discussion most conveniently select #EULARJC to follow throughout. We recommend you include it in every tweet to make sure it reaches us.

Please click here to look at previous editions of the EULAR-EMEUNET Journal Club.

 

EMEUNET PAPER OF THE MONTH

The winner of the POM is Andreas Kronbichler from at the Department of Internal Medicine IV (Nephrology and Hypertension), Medizinische Universität Innsbruck.

Diederik De Cock and  Polona Zigon interviewed him on his study published in the Annals of the Rheumatic Diseases entitled "Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis"

Read the paper here: https://ard.bmj.com/content/annrheumdis/77/10/1440.full.pdf

and watch the video on our EMEUNET TUBE channel.


 

Don’t forget to follow us @EULAR_JC @eular_org and @EMEUNET for details of our upcoming JC!

 

Browse our tweet feed on the right to scroll through the last EULAR-EMEUNET JC!

Find the Press review newsletter of the last edition (September 2018) here

 

 

Your EULAR - EMEUNET Journal Club Team